Journal article
The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
Abstract
GUIDELINE QUESTION: Is there a role for the use of gemcitabine in the treatment of patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)?
OBJECTIVE: To make recommendations about the use of gemcitabine in the management of medically appropriate patients with stage IIIB-IV NSCLC.
Authors
Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
Journal
Cancer prevention & control : CPC = Prévention & contrôle en cancérologie : PCC, Vol. 3, No. 1, pp. 84–94
Publication Date
February 1999
ISSN
1206-548X
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Antimetabolites, AntineoplasticAntineoplastic AgentsAntineoplastic Agents, PhytogenicAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Non-Small-Cell LungCisplatinClinical Trials, Phase II as TopicConfidence IntervalsDeoxycytidineDose-Response Relationship, DrugEtoposideHumansLung NeoplasmsNeoplasm StagingNeutropeniaOdds RatioRandomized Controlled Trials as TopicRemission InductionSalvage TherapySurvival RateTreatment OutcomeGemcitabine